FDAFDA · Food and drugs·Recall number D-1271-2020
Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50
Published May 27, 2020 · Recall initiated: May 5, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ALOPRIM
- Manufacturer
- Mylan Institutional LLC
- Distributor
- Distributed Nationwide in the USA
- Lot
- Lot #: Lot N1700771, EXP October 2020; Lot N1800127, EXP February 2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.